Cannabis cultivation growth cycles
Cannabis is considered a photosensitive plant, meaning the number of light hours for which the plant is exposed daily will trigger particular responses. It is one of the few annual plants that have separate male
and female plants and can be grown from either seed stock or a clone (a cutting from a mature female plant that contains identical genetic information).
Minimizing the illicit market for cannabis in the US
Adult-use and medical cannabis legalization in the United States has reduced the overall size of illicit markets in legalized jurisdictions. Despite these reductions, a sizeable illicit market for cannabis
continues to thrive in every legalized jurisdiction and undermines the benefits which legalized cannabis offers.
Patient privacy and MMJ medical registries
Among the 33 states with medical cannabis laws, several have patient registries that track medical cannabis use.1 Given the current federal landscape and the increasing number of hacking attempts on U.S. systems, a detailed patient registry raises critical concerns.
As a growing number of states adopt medical and adult-use cannabis laws, increased attention has been placed on cannabis-impaired driving and the policies that government officials can advance to proactively
address this important issue. The following paper provides relevant background on cannabis-impaired driving as well as best practices that government officials can incorporate into their broader cannabis
policy reform efforts.
Establishing sound tax policy is a key component of state and local cannabis reform efforts. In order to support a safe, well-regulated, and successful cannabis industry, it is imperative that governments set
appropriate tax rates. The total demand for cannabis in the U.S. (including the illicit market) is estimated to be around $52.5 billion annually.
Myth vs. fact
Opponents of medical and adult-use cannabis laws often make bold claims about the negative impact cannabis will have on individuals and communities. Examples of these claims include arguments that
cannabis is a “gateway drug,” that legalization will double traffic fatalities, or that cannabis use results in increased levels of drug abuse and addiction.
As state and local governments seek to regulate the cannabis industry, several common misconceptions have led to policy makers either banning or placing undue restrictions on the means
and methods of making cannabis concentrates and extracts.
Weedmaps GR overview
Weedmaps’ mission is to power a transparent and inclusive global cannabis economy, and has been a driving force behind much of the medical and adult-use cannabis legalization in the past decade. Founded
in Southern California in 2008, the visionary and innovative employees at Weedmaps are the architects and builders of the world’s most comprehensive cannabis-centric technology platform for both medical
patients and adult consumers.
Banking the U.S. cannabis industry
The cannabis industry’s lack of access to financial services has grown from a niche issue impacting a handful of states into a national issue impacting dozens—in fact, a majority—of states in the U.S.
Dispelling the gateway theory
Opponents of legal medical and adult-use cannabis often refer to cannabis as a “gateway drug” that increases the likelihood an individual will use harder substances, such as cocaine or heroin.
Anti-cannabis advocates also argue that legalizing cannabis could lead to an increase in opioid abuse. However, neither of these claims are supported by scientific evidence.
Get in touch
By checking this box and submitting your information to Weedmaps:
1. You consent to Weedmaps’ collection of your email address, name, phone number, business name, state, and other business information for the limited purpose of subscribing to Weedmaps’ marketing emails and other communications, curated content, newsletters, promotions, deals, sponsorships, and other WM Business-related communications (collectively, the “Authorized Communications”).
2. You acknowledge that you are not a minor as legally defined in your municipality, state, province, territory, or country.
3. You agree that Weedmaps may share your personal data with third parties for the limited purpose of providing you with the Authorized Communications.
4. You understand that you will have the opportunity to unsubscribe from the Authorized Communications and request the deletion of your personal data from Weedmaps’ systems at any time.